InvestorsHub Logo
Followers 36
Posts 1166
Boards Moderated 0
Alias Born 03/07/2013

Re: Bcbrasseur post# 74854

Thursday, 04/23/2020 11:45:24 AM

Thursday, April 23, 2020 11:45:24 AM

Post# of 97094
They mentioned in a previous PR that they had tested an impedance test kit successfully for H1N1 and something like "recently for the coronavirus which has a similar structure" or words to that effect.

Reading carefully through previous PRs will give you a lot of how this came about, but they have never shared whether they've tested 5 strips on 1 sample of blood or 100 test strips against 25 samples of blood.

Previously they shared that FDA told them they needed 30 dfferent blood samples if I recall correctly of venous blood which have been verified as coming from COVID-19 patients and others confirmed not being from COVID-19 patients in order to do their testing for the FDA EUA approval process.

So he is projecting complete confidence that the kits will pass the upcoming testing, but sure would be nice to know what that confidence is based on and share that with potential investors. There's no reason I can see to withhold that info as it would generate more interest than a Fortune 500 company being interested since the company's only interested if the test is really accurate and the FDA is warning people of non accurate tests.

You want this to skyrocket, reveal some hard core data on the test kit results. (if they are good, that is)